Multiple Sclerosis Journal - October 2017 - 1508
Multiple Sclerosis Journal 23(11)
Analyses
We examined the associations between MS and number of infection-related physician visits, and MS and
number of antimicrobials prescriptions by negative
binomial regression models. As hospital admissions
are less common, we assessed the association between
MS and infection-related hospitalizations (absence vs
presence) by logistic regression models. The models
were fitted via generalized estimating equations with
an exchangeable working correlation structure, and
adjusted for sex, current age (continuous), index year
(1996-2001, 2002-2007, and 2008-2013), SES
(quintiles), immunotherapy use (not specific for MS),
and comorbidity (none, 1, and ⩾2). The logarithm of
residency time was included as an offset in the negative binomial models. Subgroup analyses included
sex and age group (18-39, 40-49, 50-59, and 60+
years). Findings were reported as adjusted incidence
rate ratios (aRRs) or adjusted odds ratios (aORs).
Similar approaches were taken for the five most common infection groups and drug classes, except for
hospitalizations, where due to low frequencies we
assessed the number of admissions over the entire
study period using negative binomial regression.
Prompted by the observation of sex differences in the
primary analyses, sex differences were also explored
across these outcomes.
Complementary analyses included (1) censoring follow-up time at initiation of a MS-specific immunomodulatory drug (Supplementary Appendix e-1,
Table e-1a) and (2) combining infection-related
encounters occurring within each 2-week period into
one to minimize the impact of repeated encounters for
the same infection. Analyses were performed separately for hospital, physician, and prescription data
using the same approach as the main analyses.
Statistical analyses were performed using IBM SPSS
Statistics Version 22 (IBM, Armonk, NY, USA) and
SAS, Version 9.4 (SAS Institute, Cary, NC, USA).
Results
Between 1996 and 2013, we identified 7179 persons
with MS and 35,837 matched controls from the general population. For both populations, the mean age at
the index date was 45.4 years and 73.8% were women
(Table 1).
Infection-related hospitalizations
People with MS were more than twice as likely to
be hospitalized for infections (aOR: 2.39; 95%
1508
confidence interval (CI): 2.16-2.65) as the matched
controls were (Table 2; model 3). The difference in
hospitalization risk between people with and without
MS was greater among men (aOR: 3.03; 95% CI:
2.50-3.68) than among women (aOR: 2.19; 95% CI:
1.95-2.46). Infection-related hospitalizations were
more frequent in MS across all age groups, rising
from a 1.5-fold increased risk in those under 40 years
of age, to a 2.7-fold increased risk in those aged
⩾60 years. Infections that prompted the highest number of hospitalizations in the total cohort were infections of the urinary system (32/10,000 person-years
(PY)), pneumonia (17/10,000 PY), intestinal infections (11/10,000 PY), infections of the skin and subcutaneous tissue (8/10,000 PY), and sepsis (8/10,000
PY). People with MS had more hospitalizations for
each of these types of infections, with the greatest difference being for infections of the urinary system
(aRR: 3.26; 95% CI: 3.10-3.43) (Table 2; model 3).
The post hoc analyses exploring sex-related differences across the five most common infection groups
showed that men with MS generally had a higher relative risk than women. This was particularly evident
for infections of the urinary system (the aRR for men
with MS relative to men without MS was 6.43 (95%
CI: 4.57-9.06); the equivalent aRR for women was
2.74 (95% CI: 2.26-3.31); Figure 1).
Infection-related physician visits
People with MS had 41% (aRR: 1.41; 95% CI: 1.36-
1.47) more infection-related physician visits than the
matched controls (Table 3; model 3). This difference
was greater among men (aRR: 1.69; 95% CI: 1.52-
1.87) than women (aRR: 1.35; 95% CI: 1.29-1.40).
Infection-related physician visits were elevated in MS
across all age groups, rising from 25% more visits in
those under 40 years of age, to 63% in those aged
⩾60 years. Infections that prompted the highest number of physician visits in the total cohort were upper
respiratory tract infections (2210/10,000 PY), infections of the urinary system (978/10,000 PY), bronchitis and bronchiolitis (892/10,000 PY), infections of
the skin and subcutaneous tissue (869/10,000 PY),
and pneumonia (367/10,000 PY). People with MS
had more physician visits for all of these types of
infections except for upper respiratory tract infections, for which no significant difference was found.
The greatest differences between people with and
without MS were for infections of the urinary system
(aRR: 2.20; 95% CI: 2.02-2.38) and pneumonia
(aRR: 2.05; 95% CI: 1.75-2.40) (Table 3; model 3),
with men exhibiting a greater burden than women
when compared to men and women in the matched
populations, respectively (Figure 1).
journals.sagepub.com/home/msj
https://journals.sagepub.com/home/msj
Table of Contents for the Digital Edition of Multiple Sclerosis Journal - October 2017
Contents
Multiple Sclerosis Journal - October 2017 - Cover1
Multiple Sclerosis Journal - October 2017 - Cover2
Multiple Sclerosis Journal - October 2017 - Contents
Multiple Sclerosis Journal - October 2017 - ii
Multiple Sclerosis Journal - October 2017 - iii
Multiple Sclerosis Journal - October 2017 - 1436
Multiple Sclerosis Journal - October 2017 - 1437
Multiple Sclerosis Journal - October 2017 - 1438
Multiple Sclerosis Journal - October 2017 - 1439
Multiple Sclerosis Journal - October 2017 - 1440
Multiple Sclerosis Journal - October 2017 - 1441
Multiple Sclerosis Journal - October 2017 - 1442
Multiple Sclerosis Journal - October 2017 - 1443
Multiple Sclerosis Journal - October 2017 - 1444
Multiple Sclerosis Journal - October 2017 - 1445
Multiple Sclerosis Journal - October 2017 - 1446
Multiple Sclerosis Journal - October 2017 - 1447
Multiple Sclerosis Journal - October 2017 - 1448
Multiple Sclerosis Journal - October 2017 - 1449
Multiple Sclerosis Journal - October 2017 - 1450
Multiple Sclerosis Journal - October 2017 - 1451
Multiple Sclerosis Journal - October 2017 - 1452
Multiple Sclerosis Journal - October 2017 - 1453
Multiple Sclerosis Journal - October 2017 - 1454
Multiple Sclerosis Journal - October 2017 - 1455
Multiple Sclerosis Journal - October 2017 - 1456
Multiple Sclerosis Journal - October 2017 - 1457
Multiple Sclerosis Journal - October 2017 - 1458
Multiple Sclerosis Journal - October 2017 - 1459
Multiple Sclerosis Journal - October 2017 - 1460
Multiple Sclerosis Journal - October 2017 - 1461
Multiple Sclerosis Journal - October 2017 - 1462
Multiple Sclerosis Journal - October 2017 - 1463
Multiple Sclerosis Journal - October 2017 - 1464
Multiple Sclerosis Journal - October 2017 - 1465
Multiple Sclerosis Journal - October 2017 - 1466
Multiple Sclerosis Journal - October 2017 - 1467
Multiple Sclerosis Journal - October 2017 - 1468
Multiple Sclerosis Journal - October 2017 - 1469
Multiple Sclerosis Journal - October 2017 - 1470
Multiple Sclerosis Journal - October 2017 - 1471
Multiple Sclerosis Journal - October 2017 - 1472
Multiple Sclerosis Journal - October 2017 - 1473
Multiple Sclerosis Journal - October 2017 - 1474
Multiple Sclerosis Journal - October 2017 - 1475
Multiple Sclerosis Journal - October 2017 - 1476
Multiple Sclerosis Journal - October 2017 - 1477
Multiple Sclerosis Journal - October 2017 - 1478
Multiple Sclerosis Journal - October 2017 - 1479
Multiple Sclerosis Journal - October 2017 - 1480
Multiple Sclerosis Journal - October 2017 - 1481
Multiple Sclerosis Journal - October 2017 - 1482
Multiple Sclerosis Journal - October 2017 - 1483
Multiple Sclerosis Journal - October 2017 - 1484
Multiple Sclerosis Journal - October 2017 - 1485
Multiple Sclerosis Journal - October 2017 - 1486
Multiple Sclerosis Journal - October 2017 - 1487
Multiple Sclerosis Journal - October 2017 - 1488
Multiple Sclerosis Journal - October 2017 - 1489
Multiple Sclerosis Journal - October 2017 - 1490
Multiple Sclerosis Journal - October 2017 - 1491
Multiple Sclerosis Journal - October 2017 - 1492
Multiple Sclerosis Journal - October 2017 - 1493
Multiple Sclerosis Journal - October 2017 - 1494
Multiple Sclerosis Journal - October 2017 - 1495
Multiple Sclerosis Journal - October 2017 - 1496
Multiple Sclerosis Journal - October 2017 - 1497
Multiple Sclerosis Journal - October 2017 - 1498
Multiple Sclerosis Journal - October 2017 - 1499
Multiple Sclerosis Journal - October 2017 - 1500
Multiple Sclerosis Journal - October 2017 - 1501
Multiple Sclerosis Journal - October 2017 - 1502
Multiple Sclerosis Journal - October 2017 - 1503
Multiple Sclerosis Journal - October 2017 - 1504
Multiple Sclerosis Journal - October 2017 - 1505
Multiple Sclerosis Journal - October 2017 - 1506
Multiple Sclerosis Journal - October 2017 - 1507
Multiple Sclerosis Journal - October 2017 - 1508
Multiple Sclerosis Journal - October 2017 - 1509
Multiple Sclerosis Journal - October 2017 - 1510
Multiple Sclerosis Journal - October 2017 - 1511
Multiple Sclerosis Journal - October 2017 - 1512
Multiple Sclerosis Journal - October 2017 - 1513
Multiple Sclerosis Journal - October 2017 - 1514
Multiple Sclerosis Journal - October 2017 - 1515
Multiple Sclerosis Journal - October 2017 - 1516
Multiple Sclerosis Journal - October 2017 - 1517
Multiple Sclerosis Journal - October 2017 - 1518
Multiple Sclerosis Journal - October 2017 - 1519
Multiple Sclerosis Journal - October 2017 - 1520
Multiple Sclerosis Journal - October 2017 - 1521
Multiple Sclerosis Journal - October 2017 - 1522
Multiple Sclerosis Journal - October 2017 - 1523
Multiple Sclerosis Journal - October 2017 - 1524
Multiple Sclerosis Journal - October 2017 - 1525
Multiple Sclerosis Journal - October 2017 - 1526
Multiple Sclerosis Journal - October 2017 - 1527
Multiple Sclerosis Journal - October 2017 - 1528
Multiple Sclerosis Journal - October 2017 - 1529
Multiple Sclerosis Journal - October 2017 - 1530
Multiple Sclerosis Journal - October 2017 - 1531
Multiple Sclerosis Journal - October 2017 - 1532
Multiple Sclerosis Journal - October 2017 - 1533
Multiple Sclerosis Journal - October 2017 - 1534
Multiple Sclerosis Journal - October 2017 - 1535
Multiple Sclerosis Journal - October 2017 - 1536
Multiple Sclerosis Journal - October 2017 - 1537
Multiple Sclerosis Journal - October 2017 - 1538
Multiple Sclerosis Journal - October 2017 - 1539
Multiple Sclerosis Journal - October 2017 - 1540
Multiple Sclerosis Journal - October 2017 - 1541
Multiple Sclerosis Journal - October 2017 - 1542
Multiple Sclerosis Journal - October 2017 - 1543
Multiple Sclerosis Journal - October 2017 - 1544
Multiple Sclerosis Journal - October 2017 - 1545
Multiple Sclerosis Journal - October 2017 - 1546
Multiple Sclerosis Journal - October 2017 - 1547
Multiple Sclerosis Journal - October 2017 - 1548
Multiple Sclerosis Journal - October 2017 - 1549
Multiple Sclerosis Journal - October 2017 - 1550
Multiple Sclerosis Journal - October 2017 - 1551
Multiple Sclerosis Journal - October 2017 - 1552
Multiple Sclerosis Journal - October 2017 - 1553
Multiple Sclerosis Journal - October 2017 - 1554
Multiple Sclerosis Journal - October 2017 - 1555
Multiple Sclerosis Journal - October 2017 - 1556
Multiple Sclerosis Journal - October 2017 - 1557
Multiple Sclerosis Journal - October 2017 - 1558
Multiple Sclerosis Journal - October 2017 - 1559
Multiple Sclerosis Journal - October 2017 - 1560
Multiple Sclerosis Journal - October 2017 - 1561
Multiple Sclerosis Journal - October 2017 - 1562
Multiple Sclerosis Journal - October 2017 - 1563
Multiple Sclerosis Journal - October 2017 - 1564
Multiple Sclerosis Journal - October 2017 - 1565
Multiple Sclerosis Journal - October 2017 - 1566
Multiple Sclerosis Journal - October 2017 - Cover3
Multiple Sclerosis Journal - October 2017 - Cover4
https://www.nxtbookmedia.com